Where is OWise located?

OWise is headquartered in London, United Kingdom.

Who is the current CEO of OWise?

Anne Bruinvels and Anne Bruinvels s of OWise. Anne Bruinvels has also founded 2 companies.

How many employees does OWise have?

As of Apr 30, 2026, the latest employee count at OWise is 7.

Is OWise a funded company?

OWise is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does OWise rank among its competitors?

OWise ranks 2nd amongst 15 active competitors, only 1 of which is funded. Resilience, which secured $25M in May, 2024.

Who are the top competitors of OWise?

OWise's top competitors include Resilience, Aware and PinkDetect. Among them, Resilience secured the most recent funding round in May, 2024.

OWise - 2026 Company Profile, Team, Funding & Competitors

OWise is a funded company based in London (United Kingdom), founded in 2012 by Anne Bruinvels and Anne Bruinvels. It operates as a Provider of a personalized cancer support app. The company has 15 active competitors, including 1 that is funded. Its top competitors include companies like Resilience, Aware and PinkDetect.

Company Details

Provider of a personalized cancer support app. This application offers patients personalized medical information based on their diagnosis. It allows users to track their wellbeing, access appointments, prescriptions, and doctor's notes in one central location. The app facilitates better communication between patients and their care teams by providing a record of symptoms and side effects. The app's content is medically validated and scientifically sound, offering credible, impartial, and evidence-based information. It aims to empower patients and help them regain control during their cancer journey.

Website: owise.uk
Social
Email ID: *****@owise.uk
Part Of

Key Metrics

Founded Year

2012

Location

London, United Kingdom

Stage

Funding Raised

Investors

NHS Innovation Accelerator

Ranked

2^nd among 15 active competitors

Employee Count

7 as on Apr 30, 2026

Similar Companies

Resilience & 13 more

View OWise's full profile

OWise is a funded company. OWise has 1 institutional investor.

View details of OWise's funding rounds and investors

The founders of OWise are Anne Bruinvels and Anne Bruinvels. Anne Bruinvels and Anne Bruinvels are the CEOs of OWise.

Here are the details of OWise's key team members:

Anne Bruinvels: Founder & CEO of OWise and founder of 1 other company.
Anne Bruinvels: Founder & CEO of OWise.

View details of OWise's Founder profiles and Board Members

OWise's employee count trend

OWise has 7 employees as of Apr 26. Here is OWise's employee count trend over the years:

Uncover OWise's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OWise include Resilience, Aware and PinkDetect. Here is the list of Top 10 competitors of OWise, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Resilience 2021, Paris (France), Series A	Provider of an app for breast cancer management	$77M	Singular, Cathay Innovation & 16 others	60/100
2nd	OWise 2012, London (United Kingdom), Funding Raised	Provider of a personalized cancer support app	-	NHS Innovation Accelerator	37/100
3rd	Aware 1999, Irvine (United States), Unfunded	Provider of breast self examination products and solutions for early cancer detection	-	-	32/100
4th	PinkDetect 2023, Toronto (Canada), Unfunded	App based platform offering tools for breast health management and education	-	-	27/100
6th	DearMamma 2006, Affoltern Am Albis (Switzerland), Unfunded	App offering tools for managing breast cancer	-	-	24/100
8th	Breastcare 2020, Wurzburg (Germany), Unfunded	Platform offering breast cancer app for early detection information	-	-	24/100
9th	My Lumps 2021, Tampa (United States), Unfunded	Mobile app for tracking breast lumps	-	-	20/100
10th	Feel For Your Life 2018, Sacramento (United States), Unfunded	Mobile app for monitoring the symptoms associated with breast cancer	-	-	18/100